期刊： JOURNAL OF HEPATOLOGY, 2022; 77 (2)
Background & Aims: The hepatic manifestation of the metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), can lead to the development of ......
期刊： JOURNAL OF HEPATOLOGY, 2022; 77 (2)
Background & Aims: The liver is a metabolically active organ and is also 'tolerogenic', exhibiting sophisticated mechanisms of immune regulation t......
期刊： JOURNAL OF HEPATOLOGY, 2022; 77 (2)
Background & Aims: The highly proliferative nature of hepato-cellular carcinoma (HCC) frequently results in a hypoxic intra-tumoural microenvironm......
期刊： JOURNAL OF HEPATOLOGY, 2022; 77 (1)
Background & Aims: Although the treatment of hepatocellular carcinoma (HCC) has been revolutionized by the advent of effective systemic therapies,......
期刊： JOURNAL OF HEPATOLOGY, 2022; 76 (6)
Humans harbour large quantities of microbes, including bacteria, fungi, viruses and archaea, in the gut. Patients with liver disease exhibit changes i......
